Histamine H1 receptor deletion in cholinergic neurons induces sensorimotor gating ability deficit and social impairments in mice
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histamine H1 receptor deletion in cholinergic neurons induces sensorimotor gating ability deficit and social impairments in mice
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-20
DOI
10.1038/s41467-021-21476-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effects of donepezil on phencyclidine-induced cognitive deficits in a mouse model of schizophrenia
- (2018) Yi-Xuan Li et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysis
- (2018) Marc Krause et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Neurophysiological Effects of Bitopertin in Schizophrenia
- (2017) Joshua T. Kantrowitz et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The roles of histamine and its receptor ligands in central nervous system disorders: An update
- (2017) Weiwei Hu et al. PHARMACOLOGY & THERAPEUTICS
- New drug developments in psychosis: Challenges, opportunities and strategies
- (2017) Matcheri S. Keshavan et al. PROGRESS IN NEUROBIOLOGY
- Neurocognitive Graphs of First-Episode Schizophrenia and Major Depression Based on Cognitive Features
- (2017) Sugai Liang et al. Neuroscience Bulletin
- Cognitive and functional deficits in people with schizophrenia: Evidence for accelerated or exaggerated aging?
- (2017) Philip D. Harvey et al. SCHIZOPHRENIA RESEARCH
- MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer’s disease
- (2016) Qiong-Bin Zhu et al. BRAIN
- The Cholinergic System: An Emerging Drug Target for Schizophrenia
- (2016) Andrew Gibbons et al. CURRENT PHARMACEUTICAL DESIGN
- A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia
- (2016) Ragy R Girgis et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline
- (2016) Elizabeth C. Ballinger et al. NEURON
- Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions
- (2016) Maximiliano Rapanelli et al. NEUROPHARMACOLOGY
- Neural circuit dysfunction in schizophrenia: Insights from animal models
- (2016) T. Sigurdsson NEUROSCIENCE
- Reduced Prepulse Inhibition as a Biomarker of Schizophrenia
- (2016) Auxiliadora Mena et al. Frontiers in Behavioral Neuroscience
- The NMDA receptor GluN2C subunit controls cortical excitatory-inhibitory balance, neuronal oscillations and cognitive function
- (2016) Subhash C. Gupta et al. Scientific Reports
- Common Mechanisms of Excitatory and Inhibitory Imbalance in Schizophrenia and Autism Spectrum Disorders
- (2015) R. Gao et al. CURRENT MOLECULAR MEDICINE
- Antipsychotic augmentation with modafinil or armodafinil for negative symptoms of schizophrenia: Systematic review and meta-analysis of randomized controlled trials
- (2015) Chittaranjan Andrade et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Histamine H1 receptor occupancy by the new-generation antipsychotics olanzapine and quetiapine: a positron emission tomography study in healthy volunteers
- (2015) Hirotoshi Sato et al. PSYCHOPHARMACOLOGY
- How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis
- (2015) Tyrone D. Cannon TRENDS IN COGNITIVE SCIENCES
- Neuromodulation by acetylcholine: examples from schizophrenia and depression
- (2014) Michael J Higley et al. CURRENT OPINION IN NEUROBIOLOGY
- Schizophrenia: from dopaminergic to glutamatergic interventions
- (2014) Marc Laruelle CURRENT OPINION IN PHARMACOLOGY
- Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
- (2014) Mark J. Millan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Topographic Mapping between Basal Forebrain Cholinergic Neurons and the Medial Prefrontal Cortex in Mice
- (2014) Bernard Bloem et al. JOURNAL OF NEUROSCIENCE
- Histidine Decarboxylase Deficiency Causes Tourette Syndrome: Parallel Findings in Humans and Mice
- (2014) Lissandra Castellan Baldan et al. NEURON
- Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
- (2014) Paolo Fusar-Poli et al. SCHIZOPHRENIA BULLETIN
- Anhedonia, avolition, and anticipatory deficits: Assessments in animals with relevance to the negative symptoms of schizophrenia
- (2013) Samuel A. Barnes et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The histaminergic network in the brain: basic organization and role in disease
- (2013) Pertti Panula et al. NATURE REVIEWS NEUROSCIENCE
- Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap
- (2012) Judith Pratt et al. NATURE REVIEWS DRUG DISCOVERY
- Genetic architectures of psychiatric disorders: the emerging picture and its implications
- (2012) Patrick F. Sullivan et al. NATURE REVIEWS GENETICS
- Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
- (2012) Marina R. Picciotto et al. NEURON
- Elevated noise power in gamma band related to negative symptoms and memory deficit in schizophrenia
- (2012) Vanessa Suazo et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex
- (2011) Y.-C. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo
- (2011) Marie Humbert-Claude et al. PSYCHOPHARMACOLOGY
- Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
- (2011) David A. Lewis et al. TRENDS IN NEUROSCIENCES
- Decreased glutamic acid decarboxylase67 mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders
- (2009) Mia Thompson et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy
- (2009) Yu-Dong Zhou et al. NATURE MEDICINE
- Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
- (2009) Juan E Belforte et al. NATURE NEUROSCIENCE
- A robust and high-throughput Cre reporting and characterization system for the whole mouse brain
- (2009) Linda Madisen et al. NATURE NEUROSCIENCE
- Reduction of brain γ-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study
- (2009) Naoki Goto et al. SCHIZOPHRENIA RESEARCH
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- Models of schizophrenia in humans and animals based on inhibition of NMDA receptors
- (2008) Věra Bubeníková-Valešová et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia
- (2008) Colin Kehrer Frontiers in Molecular Neuroscience
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now